19 Cal. App. 5th 258
Cal. Ct. App. 5th2018Background
- Plaintiffs (California dentists) sued Dentsply alleging Cavitron Directions implied suitability for surgical use but failed to disclose that its waterlines accumulate biofilm and do not deliver sterile water, asserting UCL (fraudulent practices) and express warranty claims.
- The Cavitron is a prescription Class II FDA-regulated ultrasonic scaler, widely used for surgical and nonsurgical periodontal debridement; Directions during the class period stated it was indicated for "periodontal debridement for all types of periodontal diseases."
- Evidence at trial showed longstanding industry awareness that dental unit waterlines form biofilm, CDC/ADA guidance recommending sterile water for certain surgeries, and that conventional dental units (including Cavitron setups) do not reliably deliver sterile water.
- Class representatives (Drs. Keeley and Murray) had long experience using Cavitrons for surgery; both admitted varying levels of familiarity with biofilm issues and at times used sterile delivery methods when they deemed necessary.
- Dentsply modified its communications during litigation (2005 letters and 2006 Directions) to warn that conventional ultrasonic scalers do not deliver sterile fluids and to advise against use where asepsis is required.
- The trial court found for Dentsply, concluding dentists (the targeted, sophisticated consumer group) already knew about biofilm/waterline limits and would not likely be misled; the appellate court affirmed on substantial-evidence/failure-of-proof grounds.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Cavitron Directions were "fraudulent" under the UCL (likely to deceive reasonable targeted consumers) | Directions stating suitability for "periodontal debridement for all types" implied Cavitron delivers sterile water and is safe for surgical use | Targeted consumers are licensed dentists who know waterlines form biofilm and that Cavitrons do not deliver sterile water; Directions were not likely to mislead them | Held for Dentsply: plaintiffs failed to prove Directions likely to mislead a significant portion of reasonable, targeted dentists (substantial evidence supports trial court) |
| Whether an express warranty was created that Cavitron is suitable for surgical use | The Directions formed an express warranty that Cavitron could be used in surgery (i.e., deliver sterile water) | Directions do not promise sterile-water delivery or expressly state surgical suitability; dentists knew biofilm risk yet used device by professional judgment | Held for Dentsply: plaintiffs failed to prove breach—evidence did not compel finding Dentsply promised Cavitron safe for surgical use |
| Whether plaintiffs carried burden of proof given trial court credibility findings | Plaintiffs argued Directions wording and their own testimony supported deception/warranty breach | Dentsply pointed to CDC/ADA guidance, industry knowledge, and credibility weaknesses in plaintiffs’ experts and witnesses | Held for Dentsply: appellate review defers to trial court credibility and resolves conflicting evidence in favor of prevailing party; plaintiffs’ evidence was not uncontroverted or weighty enough |
| Role of targeted-consumer sophistication in UCL deceptive-prong analysis | Plaintiffs emphasized literal ambiguity of Directions | Dentsply emphasized that UCL deception should be assessed from viewpoint of targeted group (licensed dentists), per Lavie and South Bay distinctions | Held: Court applied targeted-consumer standard and found reasonable dentists would understand limits and take professional precautions; Directions not deceptive as to that group |
Key Cases Cited
- Tobacco II, 46 Cal.4th 298 (2009) (UCL fraudulent prong focuses on conduct and deceptive practices; distinguishes reliance requirement)
- Weinstat v. Dentsply International, Inc., 180 Cal.App.4th 1213 (2010) (prior appellate decision in this litigation addressing class certification and that Directions can create an express warranty)
- Lavie v. Procter & Gamble Co., 105 Cal.App.4th 496 (2003) (UCL deception assessed from vantage of ordinary consumer; when targeted, evaluate perspective of that group)
- Chern v. Bank of America, 15 Cal.3d 866 (1976) (deceptive practice may be established as matter of law where general public understanding is lacking)
- South Bay Chevrolet v. General Motors Acceptance Corp., 72 Cal.App.4th 861 (1999) (distinguishes Chern; where practice targets sophisticated businesses, deception assessed from their vantage)